AdminDec 1, 2021< 1 min read

Generating Synthetic Longitudinal Data

2022-03-30-Managing-and-Regulating-Privacy-Risks-in-Synthetic-Data-1

Khaled El Emam, SVP & GM, Replica Analytics; Lucy Mosquera, Director Data Science, Replica Analytics

Longitudinal data differ from other types of data to which synthesis has been applied, such as tabular data, necessitating a novel set of approaches and technologies which we illustrate in this webinar.

View Slides

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.

Learn More

RELATED ARTICLES

Prasidh ChhabriaAug 7, 20254 min read

Introducing Aetion® Activate: Accelerating RWE across the enterprise

For years, we’ve heard the same challenge voiced across advanced analytics teams in biopharma: while most are staffed for ...

AetionAug 7, 2025< 1 min read

Actions for stakeholders to develop better real-world evidence for HTA bodies/payers decision making

Real-world evidence (RWE) is essential to support decision-making by health technology assessment (HTA) bodies and payers, ...

AetionAug 4, 20253 min read

The Product Brief: Scaling Smarter Evidence Generation in 2025

Katia Druzhynina, Pippa Hodgkins, Lucy Mosquera Driven by our mission to redefine real-world evidence generation, Aetion is ...